Simola N - Search Results

1

Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions.

Simola N, Morelli M, Pinna A. Simola N, et al. Curr Pharm Des. 2008;14(15):1475-89. doi: 10.2174/138161208784480072. Curr Pharm Des. 2008. PMID: 18537671 Review.

2

Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.

Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. Simola N, et al. Exp Neurol. 2004 Sep;189(1):182-8. doi: 10.1016/j.expneurol.2004.05.027. Exp Neurol. 2004. PMID: 15296848

3

New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists.

Pinna A, Wardas J, Simola N, Morelli M. Pinna A, et al. Among authors: simola n. Life Sci. 2005 Nov 12;77(26):3259-67. doi: 10.1016/j.lfs.2005.04.029. Epub 2005 Jun 23. Life Sci. 2005. PMID: 15979104 Review.

4

Sensitization to caffeine and cross-sensitization to amphetamine: influence of individual response to caffeine.

Simola N, Cauli O, Morelli M. Simola N, et al. Behav Brain Res. 2006 Sep 15;172(1):72-9. doi: 10.1016/j.bbr.2006.04.019. Epub 2006 Jun 5. Behav Brain Res. 2006. PMID: 16740323

5

Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.

Tronci E, Simola N, Carta AR, De Luca MA, Morelli M. Tronci E, et al. Among authors: simola n. J Neurochem. 2006 Aug;98(4):1078-89. doi: 10.1111/j.1471-4159.2006.03943.x. Epub 2006 Jun 12. J Neurochem. 2006. PMID: 16771831 Free article.

6

Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.

Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. Simola N, et al. J Neurol Sci. 2006 Oct 25;248(1-2):48-52. doi: 10.1016/j.jns.2006.05.038. Epub 2006 Jun 15. J Neurol Sci. 2006. PMID: 16780890

7

Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A) receptor antagonists.

Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M. Simola N, et al. Exp Neurol. 2006 Nov;202(1):255-7. doi: 10.1016/j.expneurol.2006.05.015. Epub 2006 Jun 30. Exp Neurol. 2006. PMID: 16808917

8

Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats.

Simola N, Tronci E, Pinna A, Morelli M. Simola N, et al. Amino Acids. 2006 Nov;31(4):359-63. doi: 10.1007/s00726-006-0373-3. Epub 2006 Aug 2. Amino Acids. 2006. PMID: 16874467

9

Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.

Tronci E, Simola N, Borsini F, Schintu N, Frau L, Carminati P, Morelli M. Tronci E, et al. Among authors: simola n. Eur J Pharmacol. 2007 Jul 2;566(1-3):94-102. doi: 10.1016/j.ejphar.2007.03.021. Epub 2007 Mar 24. Eur J Pharmacol. 2007. PMID: 17445798

10

The 6-hydroxydopamine model of Parkinson's disease.

Simola N, Morelli M, Carta AR. Simola N, et al. Neurotox Res. 2007 Apr;11(3-4):151-67. doi: 10.1007/BF03033565. Neurotox Res. 2007. PMID: 17449457 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters